Artificial Pancreas Device System Market to 2025 – Global Analysis and Forecasts by Type (Control to Range, Control to Target and Threshold Suspended Device Systems)
Report Code: TIPHE100001232 No. of Pages: 150 Category: Medical Device Status: Upcoming
Artificial pancreas device system are the devices that closely copy the glucose regulating function of fit pancreas. The device not only monitors the glucose levels in the body, it also automatically adjusts the distribution of insulin to reduce high blood glucose levels and lowers the incidence of low blood glucose with less or no input from the patient.
The artificial pancreas device system market is expected to grow significantly due to the key factors such as rise in the number of diabetes incidences in growing geriatric population as well as in the young age people, increase in the technological advancement and also the support from the FDA raises the medical innovations to produce safe and effective devices for the medical industries. For instances, in October 2016, FDA approved the first hybrid closed loop system known as MiniMed 670G system of Medtronics. Thus, these factors are motivating the players to produce more devices with more advanced technology which will eventually lead to the market growth of artificial pancreas device system in future.
The “Global Artificial Pancreas Device System Market Analysis to 2025” is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global artificial pancreas device system market with detailed market segmentation by type, and geography. The global artificial pancreas device system market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
The segmentation of the artificial pancreas device system market is classified as type. The type segment is segmented into control to range, control to target and threshold suspended device systems. The largest market of artificial pancreas system is hold by the threshold suspended device systems.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global artificial pancreas device system market based on type. It also provides market size and forecast till 2025 for overall artificial pancreas device system market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
North America is hold the largest market followed by the Europe for artificial pancreas device system due to the factors such increase in the geriatric population, increase in the diabetic cases and technological advancement in the field of medical devices. The Asia Pacific region is expected to be the fastest growing region due to the increase in diabetes incidences, increase in the expenditure for the medical facilities. Thus, owing to these factors the market for artificial pancreas device system is expected to propel in coming future.
The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America.
The report also includes the profiles of key artificial pancreas device system manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are, Defymed, Beta Bionics, TypeZero Technologies, Inc., Tandem Diabetes Care, Inc., BIGFOOT BIOMEDICAL, INC., Johnson & Johnson Services, Inc., Pancreum, Inc., Medtronic, Insulet Corporation, and Admetsys.
The artificial pancreas device system market is expected to grow significantly due to the key factors such as rise in the number of diabetes incidences in growing geriatric population as well as in the young age people, increase in the technological advancement and also the support from the FDA raises the medical innovations to produce safe and effective devices for the medical industries. For instances, in October 2016, FDA approved the first hybrid closed loop system known as MiniMed 670G system of Medtronics. Thus, these factors are motivating the players to produce more devices with more advanced technology which will eventually lead to the market growth of artificial pancreas device system in future.
The “Global Artificial Pancreas Device System Market Analysis to 2025” is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global artificial pancreas device system market with detailed market segmentation by type, and geography. The global artificial pancreas device system market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
The segmentation of the artificial pancreas device system market is classified as type. The type segment is segmented into control to range, control to target and threshold suspended device systems. The largest market of artificial pancreas system is hold by the threshold suspended device systems.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global artificial pancreas device system market based on type. It also provides market size and forecast till 2025 for overall artificial pancreas device system market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
North America is hold the largest market followed by the Europe for artificial pancreas device system due to the factors such increase in the geriatric population, increase in the diabetic cases and technological advancement in the field of medical devices. The Asia Pacific region is expected to be the fastest growing region due to the increase in diabetes incidences, increase in the expenditure for the medical facilities. Thus, owing to these factors the market for artificial pancreas device system is expected to propel in coming future.
The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America.
The report also includes the profiles of key artificial pancreas device system manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are, Defymed, Beta Bionics, TypeZero Technologies, Inc., Tandem Diabetes Care, Inc., BIGFOOT BIOMEDICAL, INC., Johnson & Johnson Services, Inc., Pancreum, Inc., Medtronic, Insulet Corporation, and Admetsys.
1 Introduction
1.1 Scope of Study
1.2 The Insight Partners Research Report Guidance
2 Key Takeaways
3 Artificial Pancreas Device System Market Landscape
3.1 Market Overview
3.2 Market Segmentation
3.2.1 Artificial Pancreas Device System Market – By Type
3.2.2 Artificial Pancreas Device System – By Region
3.2.2.1 By Country
3.3 PEST Analysis
3.3.1 North America – PEST Analysis
3.3.2 Europe – PEST Analysis
3.3.3 Asia Pacific – PEST Analysis
3.3.4 Middle East and Africa – PEST Analysis
3.3.5 South and Central America– PEST Analysis
4 Artificial Pancreas Device System Market – Key Industry Dynamics
4.1 Key Market Drivers
4.2 Key Market Restraints
4.3 Key Market Opportunities
4.4 Future Trends
4.5 Impact Analysis
5 Artificial Pancreas Device System Market – Global Analysis
5.1 Global Artificial Pancreas Device System Market Overview
5.2 Global Artificial Pancreas Device System Market Revenue Forecasts and Analysis (US$ Mn)
5.3 Market Positioning/Market Share
5.4 Performance of Key Players
5.5 Expert Opinions
6 Artificial Pancreas Device System Market- Global Regulatory Scenario
6.1 Overview
6.2 North America
6.3 Europe
6.4 Asia Pacific
6.5 Middle East & Africa
6.6 South and Central America
7 Artificial Pancreas Device System Market Revenue and Forecasts to 2025 – By Type
7.1 Overview
7.2 Type Market Revenue and Forecasts Analysis (US$ Mn)
7.3 Control to Range Market
7.3.1 Overview
7.3.2 Control to Range Market Revenue Forecasts and Analysis (US$ Mn)
7.4 Control to Target Market
7.4.1 Overview
7.4.2 Control to Target Market Revenue Forecasts and Analysis (US$ Mn)
7.5 Threshold Suspended Device System Market
7.5.1 Overview
7.5.2 Threshold Suspended Device System Market Revenue Forecasts and Analysis (US$ Mn)
8 North America Artificial Pancreas Device System Market Revenue and Forecasts to 2025 – Country Analysis
8.1 North America Artificial Pancreas Device System Market Overview
8.2 North America Artificial Pancreas Device System Market Revenue Forecasts and Analysis (US$ Mn)
8.3 North America Artificial Pancreas Device System Market Revenue and Forecasts Analysis – By Type (US$ Mn)
8.4 North America Artificial Pancreas Device System Market Revenue Forecasts and Analysis – By Country
8.5 US Market Overview
8.5.1 US Artificial Pancreas Device System Market Revenue Forecasts and Analysis - By Type (US$ Mn)
8.6 Canada Market Overview
8.6.1 Canada Artificial Pancreas Device System Market Revenue Forecasts and Analysis - By Type (US$ Mn)
8.7 Mexico Market Overview
8.7.1 Mexico Artificial Pancreas Device System Market Revenue Forecasts and Analysis-By Type (US$ Mn)
9 Europe Artificial Pancreas Device System Market Revenue and Forecasts to 2025 – Country Analysis
9.1 Europe Artificial Pancreas Device System Market Overview
9.2 Europe Artificial Pancreas Device System Market Revenue Forecasts and Analysis (US$ Mn)
9.3 Europe Artificial Pancreas Device System Market Revenue and Forecasts Analysis – By Type (US$ Mn)
9.4 Europe Artificial Pancreas Device System Market Revenue Forecasts and Analysis – By Country
9.5 UK Market Overview
9.5.1 UK Artificial Pancreas Device System Market Revenue Forecasts and Analysis - By Type (US$ Mn)
9.6 Germany Market Overview
9.6.1 Germany Artificial Pancreas Device System Market Revenue Forecasts and Analysis - By Type (US$ Mn)
9.7 France Market Overview
9.7.1 France Artificial Pancreas Device System Market Revenue Forecasts and Analysis-By Type (US$ Mn)
10 Asia Pacific Artificial Pancreas Device System Market Revenue and Forecasts to 2025 – Country Analysis
10.1 Asia Pacific Artificial Pancreas Device System Market Overview
10.2 Asia Pacific Artificial Pancreas Device System Market Revenue Forecasts and Analysis (US$ Mn)
10.3 Asia Pacific Artificial Pancreas Device System Market Revenue and Forecasts Analysis – By Type (US$ Mn)
10.4 Asia Pacific Artificial Pancreas Device System Market Revenue Forecasts and Analysis – By Country
10.5 Japan Market Overview
10.5.1 Japan Artificial Pancreas Device System Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.6 China Market Overview
10.6.1 China Artificial Pancreas Device System Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.7 India Market Overview
10.7.1 India Artificial Pancreas Device System Market Revenue Forecasts and Analysis-By Type (US$ Mn)
11 Middle East and Africa (MEA) Artificial Pancreas Device System Market Revenue and Forecasts to 2025 – Country Analysis
11.1 Middle East & Africa Artificial Pancreas Device System Market Overview
11.2 Middle East & Africa Artificial Pancreas Device System Market Revenue Forecasts and Analysis (US$ Mn)
11.3 Middle East & Africa Artificial Pancreas Device System Market Revenue and Forecasts Analysis – By Type (US$ Mn)
11.4 Middle East & Africa Artificial Pancreas Device System Market Revenue Forecasts and Analysis – By Country
11.5 South Africa Market Overview
11.5.1 South Africa Artificial Pancreas Device System Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.6 Saudi Arabia Market Overview
11.6.1 Saudi Arabia Artificial Pancreas Device System Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.7 UAE Market Overview
11.7.1 UAE Artificial Pancreas Device System Market Revenue Forecasts and Analysis-By Type (US$ Mn)
12 South and Central America Artificial Pancreas Device System Market Revenue and Forecasts to 2025 – Country Analysis
12.1 South and Central America Artificial Pancreas Device System Market Overview
12.2 South and Central America Artificial Pancreas Device System Market Revenue Forecasts and Analysis (US$ Mn)
12.3 South and Central America Artificial Pancreas Device System Market Revenue and Forecasts Analysis – By Type (US$ Mn)
12.4 South and Central America Artificial Pancreas Device System Market Revenue Forecasts and Analysis – By Country
12.5 Brazil Market Overview
12.5.1 Brazil Artificial Pancreas Device System Market Revenue Forecasts and Analysis - By Type (US$ Mn)
13 Industry Landscape
13.1 Organic Growth Strategies
13.1.1 New Product Launches
13.1.2 Marketing & Promotional Activities
13.2 Inorganic Growth Strategies
13.2.1 Partnerships, Collaborations, and Joint Ventures
13.2.2 Mergers & Acquisitions
14 Artificial Pancreas Device System Market, Key Company Profiles
14.1 Defymed
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Financial Overview
14.1.4 Product Portfolio
14.1.5 Product Pipeline
14.1.6 SWOT Analysis
14.1.7 Key Developments
14.2 Beta Bionics
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Financial Overview
14.2.4 Product Portfolio
14.2.5 Product Pipeline
14.2.6 SWOT Analysis
14.2.7 Key Developments
14.3 TypeZero Technologies, Inc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Financial Overview
14.3.4 Product Portfolio
14.3.5 Product Pipeline
14.3.6 SWOT Analysis
14.3.7 Key Developments
14.4 Tandem Diabetes Care, Inc.
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Financial Overview
14.4.4 Product Portfolio
14.4.5 Product Pipeline
14.4.6 SWOT Analysis
14.4.7 Key Developments
14.5 BIGFOOT BIOMEDICAL, INC.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Financial Overview
14.5.4 Product Portfolio
14.5.5 Product Pipeline
14.5.6 SWOT Analysis
14.5.7 Key Developments
14.6 Johnson & Johnson Services, Inc.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Financial Overview
14.6.4 Product Portfolio
14.6.5 Product Pipeline
14.6.6 SWOT Analysis
14.6.7 Key Developments
14.7 Pancreum, Inc.
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Financial Overview
14.7.4 Product Portfolio
14.7.5 Product Pipeline
14.7.6 SWOT Analysis
14.7.7 Key Developments
14.8 Medtronic
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Financial Overview
14.8.4 Product Portfolio
14.8.5 Product Pipeline
14.8.6 SWOT Analysis
14.8.7 Key Developments
14.9 Insulet Corporation
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Financial Overview
14.9.4 Product Portfolio
14.9.5 Product Pipeline
14.9.6 SWOT Analysis
14.9.7 Key Developments
14.10 Admetsys
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Financial Overview
14.10.4 Product Portfolio
14.10.5 Product Pipeline
14.10.6 SWOT Analysis
14.10.7 Key Developments
15 Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
15.3 Research Methodology
1.1 Scope of Study
1.2 The Insight Partners Research Report Guidance
2 Key Takeaways
3 Artificial Pancreas Device System Market Landscape
3.1 Market Overview
3.2 Market Segmentation
3.2.1 Artificial Pancreas Device System Market – By Type
3.2.2 Artificial Pancreas Device System – By Region
3.2.2.1 By Country
3.3 PEST Analysis
3.3.1 North America – PEST Analysis
3.3.2 Europe – PEST Analysis
3.3.3 Asia Pacific – PEST Analysis
3.3.4 Middle East and Africa – PEST Analysis
3.3.5 South and Central America– PEST Analysis
4 Artificial Pancreas Device System Market – Key Industry Dynamics
4.1 Key Market Drivers
4.2 Key Market Restraints
4.3 Key Market Opportunities
4.4 Future Trends
4.5 Impact Analysis
5 Artificial Pancreas Device System Market – Global Analysis
5.1 Global Artificial Pancreas Device System Market Overview
5.2 Global Artificial Pancreas Device System Market Revenue Forecasts and Analysis (US$ Mn)
5.3 Market Positioning/Market Share
5.4 Performance of Key Players
5.5 Expert Opinions
6 Artificial Pancreas Device System Market- Global Regulatory Scenario
6.1 Overview
6.2 North America
6.3 Europe
6.4 Asia Pacific
6.5 Middle East & Africa
6.6 South and Central America
7 Artificial Pancreas Device System Market Revenue and Forecasts to 2025 – By Type
7.1 Overview
7.2 Type Market Revenue and Forecasts Analysis (US$ Mn)
7.3 Control to Range Market
7.3.1 Overview
7.3.2 Control to Range Market Revenue Forecasts and Analysis (US$ Mn)
7.4 Control to Target Market
7.4.1 Overview
7.4.2 Control to Target Market Revenue Forecasts and Analysis (US$ Mn)
7.5 Threshold Suspended Device System Market
7.5.1 Overview
7.5.2 Threshold Suspended Device System Market Revenue Forecasts and Analysis (US$ Mn)
8 North America Artificial Pancreas Device System Market Revenue and Forecasts to 2025 – Country Analysis
8.1 North America Artificial Pancreas Device System Market Overview
8.2 North America Artificial Pancreas Device System Market Revenue Forecasts and Analysis (US$ Mn)
8.3 North America Artificial Pancreas Device System Market Revenue and Forecasts Analysis – By Type (US$ Mn)
8.4 North America Artificial Pancreas Device System Market Revenue Forecasts and Analysis – By Country
8.5 US Market Overview
8.5.1 US Artificial Pancreas Device System Market Revenue Forecasts and Analysis - By Type (US$ Mn)
8.6 Canada Market Overview
8.6.1 Canada Artificial Pancreas Device System Market Revenue Forecasts and Analysis - By Type (US$ Mn)
8.7 Mexico Market Overview
8.7.1 Mexico Artificial Pancreas Device System Market Revenue Forecasts and Analysis-By Type (US$ Mn)
9 Europe Artificial Pancreas Device System Market Revenue and Forecasts to 2025 – Country Analysis
9.1 Europe Artificial Pancreas Device System Market Overview
9.2 Europe Artificial Pancreas Device System Market Revenue Forecasts and Analysis (US$ Mn)
9.3 Europe Artificial Pancreas Device System Market Revenue and Forecasts Analysis – By Type (US$ Mn)
9.4 Europe Artificial Pancreas Device System Market Revenue Forecasts and Analysis – By Country
9.5 UK Market Overview
9.5.1 UK Artificial Pancreas Device System Market Revenue Forecasts and Analysis - By Type (US$ Mn)
9.6 Germany Market Overview
9.6.1 Germany Artificial Pancreas Device System Market Revenue Forecasts and Analysis - By Type (US$ Mn)
9.7 France Market Overview
9.7.1 France Artificial Pancreas Device System Market Revenue Forecasts and Analysis-By Type (US$ Mn)
10 Asia Pacific Artificial Pancreas Device System Market Revenue and Forecasts to 2025 – Country Analysis
10.1 Asia Pacific Artificial Pancreas Device System Market Overview
10.2 Asia Pacific Artificial Pancreas Device System Market Revenue Forecasts and Analysis (US$ Mn)
10.3 Asia Pacific Artificial Pancreas Device System Market Revenue and Forecasts Analysis – By Type (US$ Mn)
10.4 Asia Pacific Artificial Pancreas Device System Market Revenue Forecasts and Analysis – By Country
10.5 Japan Market Overview
10.5.1 Japan Artificial Pancreas Device System Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.6 China Market Overview
10.6.1 China Artificial Pancreas Device System Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.7 India Market Overview
10.7.1 India Artificial Pancreas Device System Market Revenue Forecasts and Analysis-By Type (US$ Mn)
11 Middle East and Africa (MEA) Artificial Pancreas Device System Market Revenue and Forecasts to 2025 – Country Analysis
11.1 Middle East & Africa Artificial Pancreas Device System Market Overview
11.2 Middle East & Africa Artificial Pancreas Device System Market Revenue Forecasts and Analysis (US$ Mn)
11.3 Middle East & Africa Artificial Pancreas Device System Market Revenue and Forecasts Analysis – By Type (US$ Mn)
11.4 Middle East & Africa Artificial Pancreas Device System Market Revenue Forecasts and Analysis – By Country
11.5 South Africa Market Overview
11.5.1 South Africa Artificial Pancreas Device System Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.6 Saudi Arabia Market Overview
11.6.1 Saudi Arabia Artificial Pancreas Device System Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.7 UAE Market Overview
11.7.1 UAE Artificial Pancreas Device System Market Revenue Forecasts and Analysis-By Type (US$ Mn)
12 South and Central America Artificial Pancreas Device System Market Revenue and Forecasts to 2025 – Country Analysis
12.1 South and Central America Artificial Pancreas Device System Market Overview
12.2 South and Central America Artificial Pancreas Device System Market Revenue Forecasts and Analysis (US$ Mn)
12.3 South and Central America Artificial Pancreas Device System Market Revenue and Forecasts Analysis – By Type (US$ Mn)
12.4 South and Central America Artificial Pancreas Device System Market Revenue Forecasts and Analysis – By Country
12.5 Brazil Market Overview
12.5.1 Brazil Artificial Pancreas Device System Market Revenue Forecasts and Analysis - By Type (US$ Mn)
13 Industry Landscape
13.1 Organic Growth Strategies
13.1.1 New Product Launches
13.1.2 Marketing & Promotional Activities
13.2 Inorganic Growth Strategies
13.2.1 Partnerships, Collaborations, and Joint Ventures
13.2.2 Mergers & Acquisitions
14 Artificial Pancreas Device System Market, Key Company Profiles
14.1 Defymed
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Financial Overview
14.1.4 Product Portfolio
14.1.5 Product Pipeline
14.1.6 SWOT Analysis
14.1.7 Key Developments
14.2 Beta Bionics
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Financial Overview
14.2.4 Product Portfolio
14.2.5 Product Pipeline
14.2.6 SWOT Analysis
14.2.7 Key Developments
14.3 TypeZero Technologies, Inc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Financial Overview
14.3.4 Product Portfolio
14.3.5 Product Pipeline
14.3.6 SWOT Analysis
14.3.7 Key Developments
14.4 Tandem Diabetes Care, Inc.
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Financial Overview
14.4.4 Product Portfolio
14.4.5 Product Pipeline
14.4.6 SWOT Analysis
14.4.7 Key Developments
14.5 BIGFOOT BIOMEDICAL, INC.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Financial Overview
14.5.4 Product Portfolio
14.5.5 Product Pipeline
14.5.6 SWOT Analysis
14.5.7 Key Developments
14.6 Johnson & Johnson Services, Inc.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Financial Overview
14.6.4 Product Portfolio
14.6.5 Product Pipeline
14.6.6 SWOT Analysis
14.6.7 Key Developments
14.7 Pancreum, Inc.
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Financial Overview
14.7.4 Product Portfolio
14.7.5 Product Pipeline
14.7.6 SWOT Analysis
14.7.7 Key Developments
14.8 Medtronic
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Financial Overview
14.8.4 Product Portfolio
14.8.5 Product Pipeline
14.8.6 SWOT Analysis
14.8.7 Key Developments
14.9 Insulet Corporation
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Financial Overview
14.9.4 Product Portfolio
14.9.5 Product Pipeline
14.9.6 SWOT Analysis
14.9.7 Key Developments
14.10 Admetsys
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Financial Overview
14.10.4 Product Portfolio
14.10.5 Product Pipeline
14.10.6 SWOT Analysis
14.10.7 Key Developments
15 Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
15.3 Research Methodology
The List of Companies
1. Defymed
2. Beta Bionics
3. TypeZero Technologies, Inc.
4. Tandem Diabetes Care, Inc.
5. BIGFOOT BIOMEDICAL, INC.
6. Johnson & Johnson Services, Inc.
7. Pancreum, Inc.
8. Medtronic
9. Insulet Corporation
10. Admetsys
1. Defymed
2. Beta Bionics
3. TypeZero Technologies, Inc.
4. Tandem Diabetes Care, Inc.
5. BIGFOOT BIOMEDICAL, INC.
6. Johnson & Johnson Services, Inc.
7. Pancreum, Inc.
8. Medtronic
9. Insulet Corporation
10. Admetsys